Biotechnology advances the plastics industry by employing living cells and enzymes to create eco-friendly solutions and ...

Vir Biotechnology, Inc.’s VIR share price has dipped by 5.45%, which has investors questioning if this is right time to buy.

Fortress Biotech, Inc.’s FBIO share price has dipped by 6.18%, which has investors questioning if this is right time to buy.

Dr Mary Lynne Hedley, a trailblazer in biotechnology and scientific entrepreneurship, recently visited Cyprus to inspire the ...

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

Q1 2025 Earnings Call Transcript May 8, 2025 Alpha Teknova, Inc. beats earnings expectations. Reported EPS is $-0.09, ...

Fortress Biotech, Inc. ("Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to ...

This pharmaceutical biotechnology company announced a significant milestone in its global intellectual property strategy. The ...

Dr Matthias Magoola, the founder and managing director of Dei Biopharma Ltd, has been awarded one of the continent’s top ...

Deerfield Management has unveiled the third installment of its healthcare innovations fund, earmarking more than $600 million ...

BPC Instruments (publ) hereby publishes the Annual Report for the year 2024. The Annual Report is available as an attached file to this release and ...

A Beachwood-based biotechnology company has secured $20 million in financing that will enable an expansion in personnel, ...